# The HIF‐1α Pathway Regulates Satellite Cell Fate During Aging Through Histone Lactylation

**Authors:** Marco Piccoli, Lorenzo Mornatti, Ivana Lavota, Monica Risuglia, Pasquale Creo, Elena Vizzino, Paola Rota, Adriana Tarantino, Laura Mangiavini, Giuseppe Ciconte, Paola Signorelli, Giuseppe Maria Peretti, Simone Cenci, Carlo Pappone, Luigi Anastasia, Federica Cirillo

PMC · DOI: 10.1111/acel.70411 · Aging Cell · 2026-02-13

## TL;DR

This study shows that reactivating the HIF-1α pathway in aged muscle stem cells can reverse age-related decline by boosting metabolism and epigenetic changes.

## Contribution

The paper identifies a HIF-1α-lactate-lactylation axis that rejuvenates aged satellite cells and improves muscle regeneration.

## Key findings

- HIF-1α signaling declines with age and can be restored with roxadustat, increasing lactate and histone lactylation.
- HIF-1α activation reduces senescence and increases stem cell markers like Pax7 in aged satellite cells.
- Treated aged cells form larger myotubes and activate pathways linked to muscle growth and function.

## Abstract

Aging‐associated sarcopenia is driven in part by the progressive loss of type II glycolytic fibers and the functional decline of their resident stem cells, the satellite cells (SCs). We show here that these defects result from attenuation of the hypoxia‐inducible factor‐1α (HIF‐1α) signaling pathway and can be reversed by pharmacological HIF‐1α reactivation. In the tibialis anterior muscle of 18‐month‐old C57BL/6J mice, HIF‐1α protein abundance decreased by ≈46% and canonical targets (Vegfa, Egln1) were downregulated in freshly isolated SCs. Treatment of aged SCs with the prolyl hydroxylase inhibitor roxadustat (FG‐4592) for 48 h restored HIF signaling, upregulated glycolytic enzymes (HK2, GAPDH, ALDO) and the lactate transporter MCT4, and increased intracellular lactate by 1.9‐fold. Increased lactate enhanced global histone lactylation, an epigenetic mark that decreased with age. The effect was attenuated by the LDHA inhibitor oxamate, establishing a link between HIF‐driven metabolism and chromatin remodeling. HIF‐1α activation slowed old SC proliferation (S phase −60%), but decreased the senescence marker p16Ink4a (−54%) and increased the stem cell factor Pax7 (+1.8‐fold), indicating a shift from senescence to a quiescent, regenerative state. When differentiation was induced without drugs, pretreated aged SCs formed hypertrophic myotubes (differentiation index +1.7), exhibited higher ATP content (+1.54‐fold), and activated the IGF‐1/PI3K–Akt–mTOR pathway, leading to an increase in tropomyosin (Tpm1) in fast fibers. These results suggest a HIF‐1α‐lactate‐lactylation axis that rejuvenates aged satellite cells and enhances myogenic performance, providing a mechanistic rationale for repurposing roxadustat to alleviate sarcopenia.

FG‐4592–induced activation of HIF‐1α enhances anaerobic glycolysis and promotes lactate‐driven PAX7 lactylation, thereby boosting satellite cell activity and counteracting age‐related muscle decline.

## Linked entities

- **Genes:** HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422], EGLN1 (egl-9 family hypoxia inducible factor 1) [NCBI Gene 54583], HK2 (hexokinase 2) [NCBI Gene 3099], GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597], aldO (alditol oxidase) [NCBI Gene 91300232], SLC16A4 (solute carrier family 16 member 4) [NCBI Gene 9122], CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029], PAX7 (paired box 7) [NCBI Gene 5081], TPM1 (tropomyosin 1) [NCBI Gene 7168]
- **Chemicals:** roxadustat (PubChem CID 11256664), oxamate (PubChem CID 974)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Slc16a3 (solute carrier family 16 (monocarboxylic acid transporters), member 3) [NCBI Gene 80879] {aka Mct3, Mct4}, Egln1 (egl-9 family hypoxia-inducible factor 1) [NCBI Gene 112405] {aka C1orf12, HIF-PH2, HPH-2, Hif-p4h-2, ORF13, Phd2}, Pax7 (paired box 7) [NCBI Gene 18509] {aka Pax-7}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Ldha (lactate dehydrogenase A) [NCBI Gene 16828] {aka Ldh1, Ldhm, l7R2}, Cdkn2a (cyclin dependent kinase inhibitor 2A) [NCBI Gene 12578] {aka ARF-INK4a, Arf, INK4a-ARF, Ink4a/Arf, MTS1, Pctr1}, Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, Tpm1 (tropomyosin 1, alpha) [NCBI Gene 22003] {aka TM2, TPM1kappa, Tm3, Tmpa, Tpm-1, alpha-TM}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Igf1 (insulin-like growth factor 1) [NCBI Gene 16000] {aka C730016P09Rik, Igf-1, Igf-I}, Hk2 (hexokinase 2) [NCBI Gene 15277] {aka HKII}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}
- **Diseases:** sarcopenia (MESH:D055948)
- **Chemicals:** lactate (MESH:D019344), oxamate (-), FG-4592 (MESH:C584543), ATP (MESH:D000255)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12904840/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12904840/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12904840/full.md

---
Source: https://tomesphere.com/paper/PMC12904840